Avoid preclinical testing failure by understanding the complex bioanalytical and toxicology challenges associated with ADC drug development and unique ways to overcome them.
Search Results: Intertek (25)
Built on the previous success, the 11th WRIB on April 3-7, 2017 in Los Angeles/Universal…
San Diego Convention Center 111 West Harbor Drive San Diego, CA 92101 San Diego Marriott…
Overcoming Challenges in the Development and Validation of Biologics and Small Molecules in Ocular Tissues
This webinar will demonstrate how to overcome the unique challenges associated with the distinct characteristics of ocular matrices when developing and validating ocular bioanalytical methods for biologics and small molecule drugs.
Available to view on demand
This webinar will outline the changes to the April 2016 Draft Guidance for Assay Development & Validation for Immunogenicity Testing of Therapeutic Proteins and address what they mean for the industry.
Chapter 4: Analytical Comparability (chemistry, manufacturing and controls related product attributes)
This chapter summarizes the key considerations when planning and executing comparability studies covering, with examples, the strategic selection of analytical techniques, their applicability and limitations.
Expanded capacity and technologies to expedite bioanalytical studies for clients
Press release: Intertek opens new 10,000 ft² biologic medicine contract services laboratory in Manchester, UK
Intertek, a leading global quality solutions provider, today opened a 10,000 ft² bioanalytical and biopharmaceutical…
Join Intertek for a free webinar series covering the regulatory guidance, analytical and bioanalytical requirements…